Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
46 | 3 | VIROLOGY//HIV 1//AIDS RESEARCH AND HUMAN RETROVIRUSES | 102919 |
49 | 2 | VIROLOGY//HIV 1//AIDS RESEARCH AND HUMAN RETROVIRUSES | 30279 |
34364 | 1 | HIV 1 MATRIX PROTEIN P17//MATRIX PROTEIN P17//HGP 30 | 126 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | HIV 1 MATRIX PROTEIN P17 | authKW | 1250676 | 4% | 100% | 5 |
2 | MATRIX PROTEIN P17 | authKW | 1042228 | 4% | 83% | 5 |
3 | HGP 30 | authKW | 1000540 | 3% | 100% | 4 |
4 | HIVP17 | authKW | 500270 | 2% | 100% | 2 |
5 | P17 | authKW | 390442 | 6% | 20% | 8 |
6 | ACCINATION | authKW | 250135 | 1% | 100% | 1 |
7 | AIDS SURVEILLANCE | address | 250135 | 1% | 100% | 1 |
8 | AKT MEDIATED ERK PATHWAY | authKW | 250135 | 1% | 100% | 1 |
9 | ANGIOGIENESIS | authKW | 250135 | 1% | 100% | 1 |
10 | ANTIGEN CAPTURE EIA | authKW | 250135 | 1% | 100% | 1 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Immunology | 1691 | 55% | 0% | 69 |
2 | Virology | 710 | 18% | 0% | 23 |
3 | Infectious Diseases | 372 | 17% | 0% | 21 |
4 | Medicine, Research & Experimental | 107 | 12% | 0% | 15 |
5 | Microbiology | 83 | 12% | 0% | 15 |
6 | Multidisciplinary Sciences | 37 | 3% | 0% | 4 |
7 | Biochemical Research Methods | 34 | 6% | 0% | 8 |
8 | Biotechnology & Applied Microbiology | 23 | 7% | 0% | 9 |
9 | Pharmacology & Pharmacy | 18 | 10% | 0% | 12 |
10 | Biochemistry & Molecular Biology | 10 | 12% | 0% | 15 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | AIDS SURVEILLANCE | 250135 | 1% | 100% | 1 |
2 | CUSTOM BIOPHARMA SOLUT | 250135 | 1% | 100% | 1 |
3 | EXPTL PL MED | 250135 | 1% | 100% | 1 |
4 | NCOL | 250135 | 1% | 100% | 1 |
5 | VACCINOL PL MICOBIOL | 250135 | 1% | 100% | 1 |
6 | VIENNA VA | 250135 | 1% | 100% | 1 |
7 | DIPARTIMENTO MED CLIN SCI BIOCHIM | 125067 | 1% | 50% | 1 |
8 | SECT EXPT ONCOL IMMUNOL | 125065 | 2% | 25% | 2 |
9 | SEC PATHOL | 83377 | 1% | 33% | 1 |
10 | SECT ANAT PATHOL HISTOL | 83375 | 2% | 17% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HYBRIDOMA | 9639 | 7% | 0% | 9 |
2 | INFECTIOUS DISEASES IN CLINICAL PRACTICE | 8219 | 5% | 1% | 6 |
3 | NEW MICROBIOLOGICA | 5566 | 3% | 1% | 4 |
4 | VACCINE | 1343 | 8% | 0% | 10 |
5 | VIRAL IMMUNOLOGY | 840 | 2% | 0% | 2 |
6 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 727 | 3% | 0% | 4 |
7 | AIDS | 706 | 4% | 0% | 5 |
8 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 491 | 2% | 0% | 2 |
9 | PATHOGENS AND DISEASE | 478 | 1% | 0% | 1 |
10 | HIV CLINICAL TRIALS | 474 | 1% | 0% | 1 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HIV 1 MATRIX PROTEIN P17 | 1250676 | 4% | 100% | 5 | Search HIV+1+MATRIX+PROTEIN+P17 | Search HIV+1+MATRIX+PROTEIN+P17 |
2 | MATRIX PROTEIN P17 | 1042228 | 4% | 83% | 5 | Search MATRIX+PROTEIN+P17 | Search MATRIX+PROTEIN+P17 |
3 | HGP 30 | 1000540 | 3% | 100% | 4 | Search HGP+30 | Search HGP+30 |
4 | HIVP17 | 500270 | 2% | 100% | 2 | Search HIVP17 | Search HIVP17 |
5 | P17 | 390442 | 6% | 20% | 8 | Search P17 | Search P17 |
6 | ACCINATION | 250135 | 1% | 100% | 1 | Search ACCINATION | Search ACCINATION |
7 | AKT MEDIATED ERK PATHWAY | 250135 | 1% | 100% | 1 | Search AKT+MEDIATED+ERK+PATHWAY | Search AKT+MEDIATED+ERK+PATHWAY |
8 | ANGIOGIENESIS | 250135 | 1% | 100% | 1 | Search ANGIOGIENESIS | Search ANGIOGIENESIS |
9 | ANTIGEN CAPTURE EIA | 250135 | 1% | 100% | 1 | Search ANTIGEN+CAPTURE+EIA | Search ANTIGEN+CAPTURE+EIA |
10 | AT20 | 250135 | 1% | 100% | 1 | Search AT20 | Search AT20 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |